6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Latest Press Releases

Time	Headline
32m ago	GameStop Proposes to Acquire eBay at $125.00 Per Share
59m ago	XtalPi -Enabled PharmaEngine PEP08 Achieves Enrollment Milestone, with Second Synthetic Lethality Program Underway
59m ago	Applied Materials Broadens Advanced Packaging Portfolio with Acquisition of NEXX
1h ago	Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: EAI Robotics Sales Momentum Continues Along with University Collaborations and Partnership Development
2h ago	$9 Trillion Is Pouring Into American Manufacturing — And It’s Just Getting Started

About

Arcutis Biotherapeutics, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Arcutis Submits Supplemental New Drug Application to the FDA for ZORYVE® (roflumilast) Cream 0.05% to Expand Indication for Treatment of Atopic Dermatitis to Infants Down to 3 Months

Arcutis’ ZORYVE® (roflumilast) Cream Receives Strong Recommendation in American Academy of Dermatology First-Ever Pediatric Atopic Dermatitis Guidelines

Arcutis to Report First Quarter 2026 Financial Results and Host Conference Call on May 6, 2026

Arcutis Management to Present at the 25th Annual Needham Virtual Healthcare Conference

Arcutis Presents New Phase 2 Results in Infants with Atopic Dermatitis in Late-Breaking Session Today at the 2026 American Academy of Dermatology Annual Meeting

How Arcutis Biotherapeutics, Inc. runs its investor program on 6ix — audience, formats, and program overview.

Community Chat

Ask AI